Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04046211 · ClinicalTrials.gov registry record · Phase 1
Safety of Inhaled Hydrogen Gas Mixtures in Healthy Volunteers
A Phase 1 study, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT04046211 is a Phase 1 study that has completed, run by Boston Children's Hospital. The registered enrollment target is 8 participants.
The verdict
NCT04046211, a Phase 1 study, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
Hydrogen gas may decrease the degree or incidence of brain injury following ischemia. The purpose of this study is to determine the safety and tolerability of inhaled hydrogen gas at the dose exposures required for a clinical efficacy study in healthy adult participants. Participants will breathe a gas mixture that contains a low concentration of hydrogen gas in air through a high flow nasal cannula. Investigators will test for any changes in breathing and neurologic status, as well as lab tests during and following the exposure period.
Interventions
- DRUG Hydrogen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-10-26 |
| Est. Completion | 2021-05-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04046211
The ClinicalTrials.gov registry entry for NCT04046211 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hydrogen is the first listed.
NCT04046211 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04046211 about?
NCT04046211 is a clinical study titled "Safety of Inhaled Hydrogen Gas Mixtures in Healthy Volunteers". Hydrogen gas may decrease the degree or incidence of brain injury following ischemia. The purpose of this study is to determine the safety and tolerability of inhaled hydrogen gas at the dose exposures required for a clinical efficacy study in healthy adult participants. Participants will breathe a ...
What is the current status of trial NCT04046211?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2020-10-26. Estimated completion is 2021-05-01.
What interventions are being tested in trial NCT04046211?
The interventions under investigation include: Hydrogen (DRUG).
Who is sponsoring clinical trial NCT04046211?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.